GlassScriptPhysician profile
John M Forman
NPI 1992871123
$4,200.06
in general payments reported to CMS, 2019-2025
24 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $1,747 · 2021: $111 · 2022: $626 · 2023: $143 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,824.59 | 2019-2020 | |
| Silk Road Medical, INC. | $791.10 | 2019-2021 | |
| Atricure, INC. | $535.07 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $149.69 | 2019-2021 | |
| Smith+Nephew, INC. | $133.84 | 2019-2025 | Pico 14, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Edwards Lifesciences Corporation | $98.70 | 2019 | |
| Boston Scientific Corporation | $88.92 | 2021-2025 | Enroute Transcarotid Stent |
| Intuitive Surgical, INC. | $82.56 | 2023 | Da Vinci Surgical System |
| Davol INC. | $62.67 | 2020-2022 | |
| Abbott Laboratories | $60.90 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $43.13 | 2023-2025 | |
| Pfizer INC. | $42.14 | 2022 | |
| Zimmer Biomet Holdings, INC. | $34.77 | 2019 | |
| Hemosonics LLC | $32.33 | 2019 | |
| Lifenet Health | $32.32 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $27.96 | 2020 | |
| La Jolla Pharmaceutical Company | $27.76 | 2019 | |
| Artivion, INC. | $27.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.39 | 2019 | |
| Clearflow INC. | $20.59 | 2022 | |
| Titan Surgical Group, LLC | $15.80 | 2025 | |
| Kls-Martin L.P. | $14.27 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Forman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.